Patient access where medical groups excel drives higher commercial patient retention and boosts operational performance, Kaufman Hall reports.

Novo Nordisk remains a dominant business with a strong pipeline, and current multiples are low enough to justify a buy. Read my latest analysis of NVO stock.

Cigar Mile is a short-term goal for the record-priced Bishops Bay, with the Saudi Cup as the longer-term target ...